T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · Real-Time Price · USD
0.968
-0.082 (-7.81%)
At close: Oct 29, 2024, 4:00 PM
0.980
+0.012 (1.24%)
After-hours: Oct 29, 2024, 7:45 PM EDT
T2 Biosystems Revenue
T2 Biosystems had revenue of $1.95M in the quarter ending June 30, 2024, a decrease of -0.61%. This brings the company's revenue in the last twelve months to $7.16M, down -45.74% year-over-year. In the year 2023, T2 Biosystems had annual revenue of $7.19M, down -67.75%.
Revenue (ttm)
$7.16M
Revenue Growth
-45.74%
P/S Ratio
0.97
Revenue / Employee
$63,398
Employees
113
Market Cap
16.92M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.19M | -15.11M | -67.75% |
Dec 31, 2022 | 22.31M | -5.75M | -20.50% |
Dec 31, 2021 | 28.06M | 9.93M | 54.76% |
Dec 31, 2020 | 18.13M | 9.80M | 117.52% |
Dec 31, 2019 | 8.34M | -2.16M | -20.62% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
bioAffinity Technologies | 7.32M |
Sol-Gel Technologies | 6.56M |
QT Imaging Holdings | 3.11M |
TherapeuticsMD | 996.00K |
Bullfrog AI | 65.00K |
TTOO News
- 19 days ago - T2 Biosystems, Inc. (TTOO) Business Update Conference Call Transcript - Seeking Alpha
- 21 days ago - T2 Biosystems to Host Business Update Call on October 10, 2024 - GlobeNewsWire
- 22 days ago - T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens - GlobeNewsWire
- 5 weeks ago - T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union - GlobeNewsWire
- 2 months ago - T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - T2 Biosystems to Attend Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - T2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor - GlobeNewsWire